Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

9820	Companies
197077	Keywords
128165	Articles
104819	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 12/10/2025 at 15:00, 1 month 27 days ago

FDA Approves Renewal of Canalevia-CA1, Jaguar Health's Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
Jaguar Health, Inc. (NASDAQ:JAGX) receives FDA renewal for Canalevia-CA1, a prescription drug for chemotherapy-induced diarrhea (CID) in dogs, with conditional approval extended until December 2026

Veterinary Medicine Jaguar Health Canalevia-CA1 Chemotherapy-induced Diarrhea FDA Renewal
BRIEF

published on 12/08/2025 at 22:20, 1 month 29 days ago

Jaguar Health Announces Approval of Proposals at Stockholder Meeting

Crofelemer Microvillus Inclusion Disease FDA Approval Jaguar Health Stockholder Meeting
BRIEF

published on 12/08/2025 at 22:20, 1 month 29 days ago

Jaguar Health annonce l'approbation de propositions lors de l'assemblée générale des actionnaires

Crofelemer Jaguar Health Approbation De La FDA Assemblée Générale Des Actionnaires Maladie À Inclusions Microvillositaires
PRESS RELEASE

published on 12/08/2025 at 22:15, 1 month 29 days ago

Jaguar Health Reports Approval of All Proposals at December 2025 Special Meeting of Stockholders
Jaguar CEO Lisa Conte to present updates on near-term catalysts at Emerging Growth Conference; Initial results show crofelemer may extend infants' lives with MVID; Jaguar completes FDA meeting on crofelemer trial for MVID treatment

Crofelemer Jaguar Health Lisa Conte Emerging Growth Conference MVID
BRIEF

published on 12/02/2025 at 15:05, 2 months 4 days ago

Jaguar Health Seeks EMA Approval for Canalevia to Treat Dog Diarrhea

Jaguar Health European Medicines Agency Dog Diarrhea Canalevia Approval Non-antibiotic Treatment
BRIEF

published on 12/02/2025 at 15:05, 2 months 4 days ago

Jaguar Health sollicite l'approbation de l'EMA pour Canalevia dans le traitement de la diarrhée canine

Jaguar Health Agence Européenne Des Médicaments Diarrhée Du Chien Approbation De Canalevia Traitement Non Antibiotique
PRESS RELEASE

published on 12/02/2025 at 15:00, 2 months 4 days ago

Jaguar Health Makes Submission to EMA Regarding EU Approval Pathway for Canalevia for General Diarrhea in Dogs Based on Data from Completed Study
Jaguar Health, Inc. requests advice from EMA on EU approval pathway for Canalevia® in treating general diarrhea in dogs. Novel non-antibiotic approach targets a significant market gap

Jaguar Health Dogs EMA Canalevia General Diarrhea
BRIEF

published on 11/24/2025 at 15:05, 2 months 12 days ago

Jaguar Health renforce sa propriété intellectuelle grâce à un nouveau brevet pour le crofélémère dans le traitement des troubles intestinaux.

Crofelemer Jaguar Health Essais Cliniques Brevet Troubles Intestinaux
BRIEF

published on 11/24/2025 at 15:05, 2 months 12 days ago

Jaguar Health Strengthens IP with New Patent for Crofelemer in Intestinal Disorders

Crofelemer Patent Clinical Trials Jaguar Health Intestinal Disorders
PRESS RELEASE

published on 11/24/2025 at 15:00, 2 months 12 days ago

Jaguar Health Secures New Patent for Crofelemer in Short Bowel Syndrome, Strengthening Global IP Position Ahead of Additional Clinical Milestones
Jaguar Health, Inc. secures new patent expanding international IP for crofelemer in pediatric intestinal failure disorders, highlighting reductions in parenteral support. Supporting business development plans

Crofelemer Business Development Jaguar Health Inc. Pediatric Intestinal Failure New Patent

Accesswire

Published on 02/07/2026 at 01:00, 6 hours 7 minutes ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 7 hours 57 minutes ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 9 hours 6 minutes ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 15 hours 37 minutes ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 17 hours 37 minutes ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange

View all ACCESSWIRE

EQS Group

Published on 02/06/2026 at 19:25, 11 hours 41 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 13 hours 14 minutes ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG
Published on 02/06/2026 at 17:40, 13 hours 27 minutes ago

Carvolix : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.01.26.
Published on 02/06/2026 at 16:55, 14 hours 12 minutes ago

GAC MPV Serves as Official Reception Fleet for APEC China 2026, Demonstrating the Strength of Chinese Manufacturing
Published on 02/06/2026 at 15:25, 15 hours 42 minutes ago

CES 2026 Innovation Award Honoree iGarden M1 Pro Max Launches as World's First Bionic Dual-Vision Pool Cleaner

Les Echos

Published on 02/06/2026 at 18:22, 12 hours 44 minutes ago

Déclaration du nombre d’actions et droits de vote au 31 janvier 2026
Published on 02/06/2026 at 18:22, 12 hours 44 minutes ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 15 hours 5 minutes ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/06/2026 at 16:01, 15 hours 5 minutes ago

Exercice de l’option de remboursement de l'instrument subordonné FR0010093328
Published on 02/06/2026 at 07:54, 23 hours 12 minutes ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026

View all LES ECHOS COMFI WIRE